Literature DB >> 24239155

Cardiac resynchronisation therapy optimisation strategies: systematic classification, detailed analysis, minimum standards and a roadmap for development and testing.

S M Afzal Sohaib, Zachary I Whinnett, Kenneth A Ellenbogen, Christoph Stellbrink, T Alexander Quinn, Margot D Bogaard, Pierre Bordachar, Berry M van Gelder, Irene E van Geldorp, Cecilia Linde, Mathias Meine, Frits W Prinzen, Robert G Turcott, Henry M Spotnitz, Dan Wichterle, Darrel P Francis.   

Abstract

In this article an international group of CRT specialists presents a comprehensive classification system for present and future schemes for optimising CRT. This system is neutral to the measurement technology used, but focuses on little-discussed quantitative physiological requirements. We then present a rational roadmap for reliable cost-effective development and evaluation of schemes. A widely recommended approach for AV optimisation is to visually select the ideal pattern of transmitral Doppler flow. Alternatively, one could measure a variable (such as Doppler velocity time integral) and "pick the highest". More complex would be to make measurements across a range of settings and "fit a curve". In this report we provide clinicians with a critical approach to address any recommendations presented to them, as they may be many, indistinct and conflicting. We present a neutral scientific analysis of each scheme, and equip the reader with simple tools for critical evaluation. Optimisation protocols should deliver: (a) singularity, with only one region of optimality rather than several; (b) blinded test-retest reproducibility; (c) plausibility; (d) concordance between independent methods; and (e) transparency, with all steps open to scrutiny. This simple information is still not available for many optimisation schemes. Clinicians developing the habit of asking about each property in turn will find it easier to win now down the broad range of protocols currently promoted. Expectation of a sophisticated enquiry from the clinical community will encourage optimisation protocol-designers to focus on testing early (and cheaply) the basic properties that are vital for any chance of long term efficacy.
© 2013.

Entities:  

Keywords:  AV optimisation; Cardiac resynchronization therapy; Heart failure

Mesh:

Year:  2013        PMID: 24239155     DOI: 10.1016/j.ijcard.2013.10.069

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  Sex differences in optimal atrioventricular delay in patients receiving cardiac resynchronization therapy.

Authors:  Mariëlle Kloosterman; Alexander H Maass
Journal:  Clin Res Cardiol       Date:  2019-05-21       Impact factor: 5.460

Review 2.  Coronary venous system in cardiac computer tomography: Visualization, classification and role.

Authors:  Rafal Mlynarski; Agnieszka Mlynarska; Maciej Sosnowski
Journal:  World J Radiol       Date:  2014-07-28

Review 3.  Clinical Relevance Of Systematic CRT Device Optimization.

Authors:  Maurizio Lunati; Giovanni Magenta; Giuseppe Cattafi; Antonella Moreo; Giacomo Falaschi; Danilo Contardi; Emanuela Locati
Journal:  J Atr Fibrillation       Date:  2014-08-31

Review 4.  Strategies to improve cardiac resynchronization therapy.

Authors:  Kevin Vernooy; Caroline J M van Deursen; Marc Strik; Frits W Prinzen
Journal:  Nat Rev Cardiol       Date:  2014-05-20       Impact factor: 32.419

5.  Cardiac resynchronization therapy: mechanisms of action and scope for further improvement in cardiac function.

Authors:  Siana Jones; Joost Lumens; S M Afzal Sohaib; Judith A Finegold; Prapa Kanagaratnam; Mark Tanner; Edward Duncan; Philip Moore; Francisco Leyva; Mike Frenneaux; Mark Mason; Alun D Hughes; Darrel P Francis; Zachary I Whinnett
Journal:  Europace       Date:  2017-07-01       Impact factor: 5.214

6.  Comparison of Echocardiographic and Electrocardiographic Mapping for Cardiac Resynchronisation Therapy Optimisation.

Authors:  Helder Pereira; Tom A Jackson; Simon Claridge; Jonathan M Behar; Cheng Yao; Benjamin Sieniewicz; Justin Gould; Bradley Porter; Baldeep Sidhu; Jaswinder Gill; Steven Niederer; Christopher A Rinaldi
Journal:  Cardiol Res Pract       Date:  2019-02-21       Impact factor: 1.866

7.  Optimizing atrio-ventricular delay in pacemakers using potentially implantable physiological biomarkers.

Authors:  Daniel Keene; Alejandra A Miyazawa; Monika Johal; Ahran D Arnold; Nadine Ali; Khulat A Saqi; Katherine March; Leah Burden; Darrel P Francis; Zachary I Whinnett; Matthew J Shun-Shin
Journal:  Pacing Clin Electrophysiol       Date:  2022-01-28       Impact factor: 1.912

8.  Echocardiography and cardiac resynchronisation therapy, friends or foes?

Authors:  W M van Everdingen; J C Schipper; J van 't Sant; K Ramdat Misier; M Meine; M J Cramer
Journal:  Neth Heart J       Date:  2016-01       Impact factor: 2.380

9.  British randomised controlled trial of AV and VV optimization ("BRAVO") study: rationale, design, and endpoints.

Authors:  Zachary I Whinnett; S M Afzal Sohaib; Siana Jones; Andreas Kyriacou; Katherine March; Emma Coady; Jamil Mayet; Alun D Hughes; Michael Frenneaux; Darrel P Francis
Journal:  BMC Cardiovasc Disord       Date:  2014-04-03       Impact factor: 2.298

10.  Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy: The BRAVO Trial.

Authors:  Zachary I Whinnett; S M Afzal Sohaib; Mark Mason; Edward Duncan; Mark Tanner; David Lefroy; Mohamed Al-Obaidi; Sue Ellery; Francisco Leyva-Leon; Tim Betts; Mark Dayer; Paul Foley; Jon Swinburn; Martin Thomas; Raj Khiani; Tom Wong; Zaheer Yousef; Dominic Rogers; Paul R Kalra; Vignesh Dhileepan; Katherine March; James Howard; Andreas Kyriacou; Jamil Mayet; Prapa Kanagaratnam; Michael Frenneaux; Alun D Hughes; Darrel P Francis
Journal:  JACC Cardiovasc Imaging       Date:  2018-05-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.